hotspot -WSS

hotspot

author：hotspot 2025-09-03 07:53:13 - browse：734

Element Biosciences exterior -- biotech coverage from STAT — Element Biosciences exterior Element Biosciences

SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit a snag recently, with several firms reporting that their growth has slowed, stalled, or reversed. Upstart Element Biosciences is hoping it can succeed despite the challenging market conditions.

The San Diego firm launched a $290,000 sequencer, dubbed Aviti, in March 2022 and now has 150 instruments installed in more than 25 countries, according to a sales update Element shared with STAT. The modest growth comes at a time when some other players are struggling. Singular Genomics announced layoffs of 20% of its workforce earlier this year after the lackluster launch of its own sequencer. And Pacific Biosciences recently laid off nearly 200 employees after reporting disappointing first-quarter sales.

Element still has a long way to go in its bid to rival Illumina, a genomics giant that dominates 80% of the sequencing market and has more than 23,000 instruments in use around the world. That includes the NextSeq 2000, a $335,000 sequencer with a similar output to Aviti. Element is betting its blend of accuracy and a more moderate price point can help it carve out a niche of academic and biopharma customers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Eli Lilly to acquire Versanis in heated race for weight loss drugs

leisure time

hotspot

WSS

Britney Spears to release memoir, 'The Woman In Me,' later this year

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Digital health funding stays low as a new reality sets in

China sends large group of warplanes, navy ships towards Taiwan in forceful display

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Celiac disease study examines precisely how gluten triggers injury

Wikipedia

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Hepatitis C has a cure — but many Americans still lack access to it

Care demand spikes challenge UnitedHealth’s provider arm

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Sickle cell gene therapy cures need to be accessible in Africa

Bright Health sells Medicare Advantage business to Molina

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Medical leaders decry Supreme Court decision on affirmative action

Antibody drugs appear effective. Now can we make enough of them?

focus

How are insurers handling Leqembi and related scans?

Grail's uphill battle for Medicare to cover its cancer screening test

Involuntary treatment for addiction doesn't work

Why police arrested suspected Gilgo Beach killer away from his house

Superbugs, antibiotic resistance get scrutiny in congress

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

leisure time

leisure time

hotspot

focus